The Global Value of Pharyngitis Is Estimated At More Than US$ 1.679 Billion In 2026

According to a report compiled by Fact.MR, the global pharyngitis market is expected to witness sluggish growth. The market is likely to register a CAGR of 3.4% during the forecast period 2017–2026. The global pharyngitis market is also estimated to reach USD 1.679 billion by the end of 2026. Pharyngitis is the most common problem among people. Sore throats are mainly caused by the flu, colds or other diseases such as mononucleosis.

Most health care providers diagnose pharyngitis with a rapid streptococcal test. Doctors give drugs only after determining whether the infection is viral or bacterial. Accordingly, drug manufacturers are conducting research to develop more effective pharyngitis treatments. Here are some insights on how the global pharyngitis market is likely to perform over the next few years.

Download sample copy of this report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=361?AS

5 Forecast Highlights for the Global Sore throat Market

1- The Asia Pacific Excluding Japan (APEJ) is expected to maintain its dominant position in the global pharyngitis market during the forecast period. Group A streptococcal is the most common disease occurring in poor environments where poor living conditions allow the organism to be transmitted. APEJ thus provides an opportunity for pharmaceutical manufacturers. Additionally, the presence of major drug manufacturers in the region is also leading to the growth of the market.

2- North America is also expected to witness future growth. Smoking is very common among young adults and is significantly associated with sore throats. There has also been an increase in cases of acute pharyngitis diagnosed in children in the United States.

3- beta-lactam is expected to become one of the highly preferred class of drugs in the global pharyngitis market. By the end of 2026, sales of beta-lactams are estimated to approach US$500 million.

4- Retail Pharmacy and Pharmacy is projected to witness the highest growth during the forecast period 2017–2026. Retail pharmacies and drug stores are estimated to exceed USD 600 million in revenue by the end of 2026.

5- Oral drug delivery is expected to become the preferred route of drug administration because of its convenience and lowest cost. Oral drug delivery, accounting for more than half of revenue share, is estimated to exceed $1.2 billion in revenue by the end of 2026.

competition tracking

The report also introduces the companies expected to actively participate in the expansion of the global pharyngitis market by 2026.

• Pfizer
• GlaxoSmithKline PLC
• Novartis AG
• BioStar Pharmaceuticals
• Zambon Group SpA.

Get customized in this report for a specific research solution:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=361?AS

drug type

• beta lactam
• macroride
• cephalosporin
• Fluoroquinolones
• tetracycline
• other products

distribution channel

• hospital pharmacy
• Retail Pharmacy and Pharmacy
• online pharmacy

delivery method

• oral-
• vein
• intramuscular
• Other delivery methods

This report covers the following pharyngitis insights and assessments to help all participants involved in pharyngitis:

• Data on recently introduced regulations and their impact on key industries and demand for pharyngitis
• Up-to-date industrial pharyngitis with key analysis of market drivers, trends and influencing factors
• Analysis of key trends pharyngitis and changing consumer preferences in key industries.
• Changes in demand for pharyngitis and consumption of various products
• A major trend in funding by major investors from multiple countries
• New investment opportunities in a variety of technologies and types of products or services
• Comprehensive data and competitive analysis of major players in pharyngitis
• U.S. pharyngitis sales will grow at a steady rate, driven by growing consumer confidence and economic recovery.

Check out more related studies published by Fact.MR Research. US-6–99-Billion-by-the-End-of-2033 Expected to Reach 2033-Fact-MR-Analysis.html

contact :

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, Maryland 20852

USA

Phone: +1 (628) 251–1583

Email : sales@factmr.com